“…In approximately half of the patients, the metastatic disease was diagnosed. However, with the existence of advanced imaging technologies such as USG, CT, and magnetic resonance (MR), the ratio of coincidentally diagnosed RCC cases varies between 15% and 60% [3,4], with one-third of the patients suffering from the metastatic disease and despite sufficient treatment in one-third of the diagnoses cases metastases will occur [1]. Whereas the high grade of the primary tumor increases metastasis risk, the histopathological subtype (clear cell type mostly to the lungs, papillary to the lymph nodes, and chromophobe to the liver) provides a clue to which sites metastases will occur [5].…”